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Background: Herein, we present the case of a young female patient with keratoconus, who was subjected twice to
repeat keratoplasty, and each time, she experienced a corneal graft failure.
Findings: Under the suspicion of herpetic eye disease, we administered topical and systemic anti-herpetic
treatment after the second repeat keratoplasty. The postoperative course was uneventful, and the corneal graft is
clear, until recently. Immunohistochemistry and DNA-polymerase chain reaction were negative for herpes simplex
virus-1 (HSV-1) in the host cornea, but they detected HSV-1 in both transplanted corneal grafts, thereby supporting
our clinical hypothesis that graft-to-host HSV-1 infection elicited this chain reaction of complications in our patient.
Conclusion: This clinical report illustrates in a unique way the dramatic impact an unsuspected herpetic infection
in the corneal graft in cases of keratoplasty may have and underscores the necessity of suspecting and adequately
treating these distinct cases.
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Introduction
Several authors have reported the occurrence of herpetic
keratitis after penetrating keratoplasty in patients with no
history of herpetic disease [1-3]. It has been hypothesized
that graft-to-host transmission of herpes simplex virus 1
(HSV-1) may cause herpetic keratitis, which is described as
‘newly acquired’ keratitis [2,4]. However, reactivation of a la-
tent HSV-1 infection may also account for persisting corneal
epithelial defects or even corneal graft failure after penetrat-
ing keratoplasty [5]. Hereby, we present a unique case of
repeat corneal graft failure after penetrating keratoplasty,
which is associated with graft-to-host HSV-1 infection.Case report
A 45-year-old female patient presented in our outpatient
clinic in June 2008, complaining of gradual deterioration of
visual acuity in the left eye (OS) for 1 year. She had no
medical history and received no medication. Best-corrected* Correspondence: zisis.gkatzioufas@uks.eu
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in any medium, provided the original work is pvisual acuity (BCVA) was 9/10 in the right eye (OD) and
1/20 OS. Intraocular pressure (IOP) was 14 mmHg OD and
15 mmHg OS. Objective refraction was +2.5/−1.25/55° OD
and +1.5/−2.25/45° OS. Slit-lamp examination revealed
central corneal irregularity with marked thinning of the
paracentral cornea OS (Figure 1A). Scheimpflug examin-
ation confirmed this finding (central corneal thickness OS,
482 μm), and a clinical diagnosis of keratoconus was made.
After a thorough explanatory conversation, we recom-
mended a penetrating excimer laser-assisted keratoplasty
(PKP) OS, and the patient was enrolled on our waiting list.
In December 2008, the patient underwent an uneventful
PKP OS. Because of a persisting epithelial defect post-
operatively and despite topical treatment with autologous
serum, the patient was subjected to amniotic membrane
transplantation 2 weeks later. She was discharged with a
bandage contact lens and prednisolone eye drops three
times a day, ofloxacin eye drops five times a day and artifi-
cial tear drops five times a day. BCVA was 10/10 OD and
1/25 OS.
In June 2009, the patient referred to our clinic for regular
follow-up examination. Slit-lamp examination revealed a
diffuse cloudiness of the corneal graft due to the integrated
amniotic membrane, with stromal oedema and multipleis an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
Figure 1 Slit-lamp examination of the left eye. (A) Corneal
irregularity with marked thinning of the central cornea is observed
in June 2008. (B) Slit-lamp examination of the left eye after
penetrating keratoplasty revealed a diffuse cloudiness of the corneal
graft with stromal oedema (June 2009). (C) Slit-lamp examination of
the left eye in November 2009 showed an epithelial defect on the
central cornea, which did not heal despite intensive topical therapy
with autologous serum. (D) The corneal graft is clear after the
second repeat keratoplasty, and there are no signs of infection
(February 2011).
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graft had never been clear after PKP, the diagnosis of pri-
mary graft failure was made, and an intensive treatment
with corticosteroids was administered (prednisolone eye
drops hourly, prednisolone 250 mg intravenously for 3
days on a tapering dose). Despite topical and systemic cor-
tisone therapy, we did not observe a clinical improvement,
and the patient was included in our waiting list for a re-
peat keratoplasty OS. BCVA was 10/10 OD and hand
movement OS.
In July 2009, the patient underwent an uneventful repeat
PKP OS. On postoperative day 7, the corneal epithelium
was healed, and the patient was discharged on a tapering
dose of topical corticosteroids (prednisolone eye drops eight
times a day, ofloxacin eye drops four times a day for a week,
dexpanthenol eye gel five times a day). BCVA was 09/10
OD and 1/20 OS. IOP was 17 mmHg OD and 16 mmHg
OS. Follow-up examination was planned in 8 weeks. After
2 weeks, the patient was referred to our emergency clinic
with elevation of the IOP OS. IOP was 19 mmHg OD and
31 mmHg OS. Under topical therapy, the IOP was normal-
ized, and upon suspicion of steroid response, the patient
was discharged with rimexolone eye drops four times a day,
dexpanthenol five times a day and a fixed combination of
brimonidine/timolol two times a day. BCVA was 9/10 OD
and 4/10 OS.
In November 2009, the patient presented in our clinic
with a persisting epithelial defect OS, which did not heal
despite intensive topical therapy with autologous serum
(Figure 1C). In December 2009, an amniotic membranetransplantation was performed OS. After 4 weeks, the
epithelial defect was healed, and BCVA was 1/10 OS.
In October 2010, the patient presented with ocular pain
OS. BCVA was 10/10 OD and 1/10 OS. Slit-lamp examin-
ation revealed diffuse haze of the corneal graft with prom-
inent stromal oedema due to endothelial decompensation.
Anterior chamber examination showed 1+ cells, and no
Khodadoust line was observed. IOP was 18 mmHg OD
and 36 mmHg OS. The diagnosis of chronic diffuse endo-
thelial graft failure was made, and the patient was com-
menced on intensive topical and systemic treatment with
corticosteroids (prednisolone eye drops hourly, prednis-
olone 250 mg intravenous for 3 days on a tapering dose).
After 1 week, the patient was discharged with prednisol-
one eye drops eight times a day (on a tapering dose),
dexpanthenol five times a day, a fixed combination
brimonidine/timolol two times a day and methylpredni-
solone 80 mg per OS daily (on tapering dose). Nonethe-
less, clinical findings OS did not improve significantly, and
the decision for a second repeat PKP was made.
In November 2010, the patient underwent a re-repeat
PKP for chronic diffuse endothelial graft failure OS. BCVA
was 10/10 OD and 1/10 OS. IOP was 15 mmHg OD and
17 mmHg OS. Under the suspicion of herpetic eye disease,
we administered, in addition to the usual post-keratoplasty
therapy, topical and systemic anti-herpetic treatment
(acyclovir 400 mg five times a day for 4 weeks and after-
wards two times a day for 12 months, ganciclovir eye
gel once a day). Immunohistochemical analysis of the
native host cornea was negative for HSV-1 (Figure 2).
Polymerase chain reaction (PCR) confirmed the absence
of HSV-1 in the host cornea. However, immunohisto-
chemical and PCR analyses of both the first and second
corneal graft were positive for HSV-1 (Figure 2). The
sensitivity of the applied PCR technique was very high
(approximately 98%). The viral load in the first corneal
graft was 4 × 103 copies/mL, and the viral load in the
second corneal graft was 6 × 106 copies/mL. The post-
operative course after the re-repeat PKP was excellent
under systemic anti-herpetic treatment, and the corneal
graft is clear, until recently (Figure 1D).Discussion
Biswas et al. were the first to describe the clinical hypoth-
esis of graft-to-host transmission of HSV-1 [8]. Later on,
Remeijer et al. presented clinical data supporting this
clinical scenario [9]. Jhanji et al. have recently reported
an interesting case series of patients with ‘new-onset’
herpetic eye disease after ocular surgery, suggesting that
graft-to-host transmission of HSV-1 may have occurred
[4]. However, the clinical impact of graft-to-host herpetic
infection is controversial, based on the fact that such a
clinical scenario is a rare phenomenon [10].
Figure 2 Immunohistochemical analysis of the host cornea. (A) Immunohistochemical analysis of the host cornea for herpes simplex virus 1
(HSV-1) was negative (×20). (B) Immunohistochemical examination of the first corneal graft (after the first repeat keratoplasty) showed a strong
signal for HSV-1 (×20). (C) Immunohistochemical analysis of the second corneal graft (after the second repeat keratoplasty) also revealed a strong
signal for HSV-1 (×20). Scale bar = 100 μm.
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evaluating the entire clinical course of this case, our patient
suffered postoperatively from persisting corneal epithelial
defects due to impaired corneal re-epithelialization and
experienced one episode of keratouveitis as well as two
corneal graft failures. The common etiological factor
inducing this chain reaction of ‘unexplained clinical pit-
falls’ could have been HSV-1 since the herpetic eye disease
is a chameleon regarding the vast variety of clinical expres-
sions and manifestations [5]. Indeed, immunohistochemical
analysis and PCR confirmed the presence of HSV-1 in both
corneal grafts, but not in the host cornea, thereby support-
ing our clinical hypothesis that graft-to-host ping-pong
HSV-1 infection elicited this chain reaction of complica-
tions in our patient. Unfortunately, the corneoscleral ring
of the donor tissue was no longer available for HSV DNA-
PCR in this patient. Therefore, we cannot definitely exclude
a host-derived source of the HSV-1 infection. On the other
hand, the second corneal graft may have been salvaged
when the patient developed corneal graft haze and IOP ele-
vation if we had performed PCR analysis of an aqueous
humour sample for HSV or other viruses, which is an easy,
rapid and sensitive method for the confirmation of HSV in-
fection [11]. Instead, the patient was treated more inten-
sively with topical and systemic steroids, which may have
potentially aggravated the HSV infection and accelerated
the corneal graft failure.
Our clinical suspicion of ‘herpetic eye disease’ was rather
delayed, and our patient experienced the dramatic conse-
quences of an untreated herpetic infection in the post-
keratoplasty period. This clinical report illustrates in a
unique way the dramatic impact an unsuspected herpetic
infection on the corneal graft in cases of keratoplasty may
have and underscores the necessity of suspecting and ad-
equately treating these distinct cases. The application of
aqueous humour analysis either by PCR or by Goldmann-
Witmer coefficient analysis for early diagnosis of HSVinfection may be of paramount clinical importance in such
distinct cases.
All investigations performed in the manuscript were in
compliance with the Helsinki Declaration and approved
by the Ethics Committee of the University of Saarland/
Germany. Written informed consent was obtained from
the patient for publication of this report and any accom-
panying images.
Conclusion
In conclusion, it is advisable to perform analysis of an
aqueous humour sample for detection of potential viral
infection in patients with clinically suspected HSV infec-
tion after PKP in order to treat early this condition and
increase the chances of corneal graft survival.
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